Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

NCT03298581 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Plaque Psoriasis

Interventions

DRUG: Halobetasol Propionate

Sponsor

Sun Pharmaceutical Industries Limited

Collaborators

[object Object]